Estradiol Patch Dose Conversion Chart
By The HRT Index Editorial Research Team ·
Educational research only. Not medical advice, and not reviewed by a clinician. Do not start, stop, cut, or change any estradiol product without your prescriber.
The 30-second answer
There's no exact estradiol patch dose conversion chart that fits every woman. As a rough guide: 25–37.5 mcg/day is a low dose, 50 mcg/day (0.05 mg) is standard, 75 mcg/day is moderate-high, and 100 mcg/day is high — and a 50 mcg patch is generally treated like about 1 mg of oral estradiol or 0.625 mg of Premarin. Your real dose is set by your symptoms and your clinician, not by any chart, including this one.
This page is for you if
You have a current or proposed estradiol patch prescription and want to understand what 0.025, 0.0375, 0.05, 0.075, or 0.1 mg/day means before you talk with your clinician — or you're switching forms and the numbers don't seem to line up.
Not the right tool if
You're trying to change your own dose without a prescriber, convert a compounded (custom-mixed) hormone, or figure out unexplained bleeding. If you have a history of blood clots, stroke, heart attack, an estrogen-sensitive cancer, or liver disease — start with a clinician, not a chart.
The fast version: what your patch number means
On a patch, the number is the amount of estradiol delivered per day — not the total amount sitting inside the patch.
| Patch label | Same as | Dose band |
|---|---|---|
| 0.025 mg/day | 25 mcg/day | Low |
| 0.0375 mg/day | 37.5 mcg/day | Low |
| 0.05 mg/day | 50 mcg/day | Standard |
| 0.06 mg/day | 60 mcg/day | StandardBetween standard and moderate-high |
| 0.075 mg/day | 75 mcg/day | Moderate-high |
| 0.1 mg/day | 100 mcg/day | High |
"mg/day" and "mcg/day" are the same measurement written two ways (0.05 mg = 50 mcg). Patch strengths from FDA/DailyMed labels; dose-band framing from the Canadian Menopause Society equivalency table.
The honest truth about "converting" your dose
This chart cannot give you your exact personal dose. No chart can. If you want a single number to copy from your pill straight onto a patch, an actual prescriber is the only honest source of that number.
That sounds like a strange thing for a conversion page to admit. But because we're not faking precision, we can give you something far more useful than a neat-looking chart: the real dose bands, the honest reason they're approximate, and the exact questions that get you to the right dose faster. A chart that pretends 0.05 mg patch = 1.00 mg pill, full stop, is the chart that gets someone into trouble when they switch and their symptoms come back.
Use the chart below to find your band — not to self-prescribe a switch.
Find your safest next step before your consult
A few quick questions match your symptoms, route, risk flags, insurance, and state to the right path, and tell you if you should be seen in person first.
Find My HRT Path →Estradiol patch dose conversion chart
Approximate dose-band reference for discussion — not a self-dosing tool. Sources genuinely disagree at higher doses, and individual absorption varies. Your correct dose is set by your symptoms and your clinician.
| Estradiol patch (mg/day · mcg) | Oral estradiol (Estrace / generic) | Premarin (conjugated estrogens) | Dose band |
|---|---|---|---|
| 0.014 · 14 mcg (Menostar) | — | — | Bone onlyNot a hot-flash dose — osteoporosis prevention only |
| 0.025 · 25 mcg | ~0.5 mg | ~0.3 mg | Low |
| 0.0375 · 37.5 mcg | ~0.5 mg | ~0.3 mg | Low |
| 0.05 · 50 mcg | ~1 mg | ~0.625 mg | StandardMain anchor — most agreed-upon point |
| 0.06 · 60 mcg | Between standard and moderate-high | — | Between standard and moderate-high |
| 0.075 · 75 mcg | ~2 mg | Between 0.625 and 1.25 mg | Moderate-high |
| 0.1 · 100 mcg | ~3–4 mg (some references use ~2 mg) | ~1.25 mg | High |
Patch strengths are FDA/DailyMed label facts. Oral estradiol, Premarin, and dose-band equivalents are approximate guidance from the Canadian Menopause Society equivalency table — not exact conversions. The 50 mcg ≈ 1 mg oral estradiol ≈ 0.625 mg Premarin anchor is the point sources agree on most; the higher-dose numbers vary between references (explained below). Gel and spray doses are covered in a separate section further down — they're measured differently.
The standard anchor: why 50 mcg = 1 mg has real trial support
The KEEPS study directly compared 0.45 mg of oral conjugated estrogens with a 50 mcg/day patch and found similar relief of hot flashes and night sweats — which is why clinicians treat that dose as the same ballpark (Santoro et al., Menopause, 2017). And the practical reference to remember: 1 mg oral estradiol ≈ 50 mcg/day patch ≈ 0.625 mg Premarin (Canadian Menopause Society).
What the numbers on your estradiol patch actually mean
On a patch, the number is the estradiol delivered through your skin per day — not the total amount of drug inside the patch. A 0.05 mg/day patch holds far more than 0.05 mg, because it's built to release medication slowly over several days. That's why a used patch still contains active hormone and gets folded shut and thrown away carefully (FDA/DailyMed label).
mg vs mcg
0.05 mg/day and 50 mcg/day are identical. There are 1,000 micrograms (mcg) in a milligram (mg). Charts and pharmacies switch between the two, which makes one dose look like two different things.
Delivery rate, not contents
The "0.05" is a delivery rate — how much crosses your skin each day. Compare that to a pill, where the number is simply how much you swallow. Different math, same goal.
Schedule is not strength
A patch changed twice a week and a patch changed once a week can deliver the exact same 50 mcg/day. Same daily dose, different routine.
What estradiol patch dose equals 1 mg of oral estradiol?
In common menopause dose-band charts, 1 mg of oral estradiol sits in the same "standard" band as a 0.05 mg/day (50 mcg) patch. That's the cleanest, most agreed-upon anchor in the whole conversion. It does not mean you can switch straight from a 1 mg pill to a 50 mcg patch on your own, because a pill and a patch travel through your body differently.
The practical reference: 1 mg oral estradiol ≈ 50 mcg/day patch ≈ 0.625 mg Premarin (Canadian Menopause Society).
Why it isn't a perfect one-to-one swap comes down to first-pass metabolism — when you swallow estrogen, it passes through your liver before reaching the rest of your body, and the liver breaks a lot of it down and changes how it acts. A patch skips that trip. So even at "equivalent" doses, a pill and a patch don't behave identically — which is why a route change is a clinician conversation, not a copy-paste from a chart.
What estradiol patch dose equals Premarin 0.625?
A 0.05 mg/day (50 mcg) estradiol patch is generally considered comparable to about 0.625 mg of Premarin (conjugated estrogens — a mix of several estrogens, not pure estradiol). In the KEEPS trial, 0.45 mg of conjugated estrogens and a 50 mcg patch relieved hot flashes and night sweats about equally (Santoro et al., Menopause, 2017).
Because Premarin is a blend rather than pure estradiol, comparing it to a patch is a little looser than comparing an estradiol pill to a patch. The band is close enough to be useful for a conversation, and not precise enough to self-manage.
What estradiol patch dose equals 2 mg of oral estradiol?
In the Canadian Menopause Society table, 2 mg of oral estradiol lines up with a 75 mcg/day patch — the moderate-high band. Some older pharmacokinetic references put 2 mg closer to a 100 mcg patch instead. Either way, it's a mid-to-high systemic dose, and the exact target is a prescriber decision.
That split — is 2 mg a 75 or a 100 mcg patch? — is a small preview of why exact charts can mislead.
Is a 0.025, 0.05, or 0.1 estradiol patch a low or high dose?
A 0.025 mg/day patch (25 mcg) is a low systemic dose, 0.05 mg/day (50 mcg) is the standard anchor, and 0.1 mg/day (100 mcg) is a high systemic dose. "Systemic" means it's meant to raise estrogen throughout your whole body — different from a low, local vaginal dose.
| Patch label | mcg/day | Dose band |
|---|---|---|
| 0.025 mg/day | 25 mcg/day | Low |
| 0.0375 mg/day | 37.5 mcg/day | Low |
| 0.05 mg/day | 50 mcg/day | Standard |
| 0.06 mg/day | 60 mcg/day | Between standard and moderate-high |
| 0.075 mg/day | 75 mcg/day | Moderate-high |
| 0.1 mg/day | 100 mcg/day | High |
One thing worth saying clearly: higher is not automatically better. The goal is the lowest dose that controls your symptoms, and standard guidance is to revisit with your doctor every 3 to 6 months about whether a lower dose or stopping makes sense (MedlinePlus). A "low" 0.0375 patch isn't weak or pointless — some twice-weekly patch labels use 0.0375 mg/day as a starting dose for moderate to severe hot flashes (FDA prescribing label).
Why isn't there one exact estradiol conversion chart?
Because the science underneath it is genuinely fuzzy, and honest sources admit it. There are very few studies that put these products head-to-head, blood estradiol doesn't rise in a neat straight line with dose, and different references line up the higher doses differently.
The higher-dose conversions genuinely disagree
The Canadian Menopause Society lines up a 100 mcg patch with 3–4 mg of oral estradiol. Older pharmacokinetic studies compared a 100 mcg patch with about 2 mg. Both numbers are in real clinical use. That gap isn't a mistake on this page — it's the actual state of the evidence.
There aren't many head-to-head trials
Most equivalence figures come from stitching together separate studies — not from one big trial that put every product side by side. The Canadian Menopause Society's own table says its equivalencies aren't based on complete head-to-head comparisons and should be adjusted to your response and tolerability.
Blood levels don't track dose in a straight line
In one study, 1 mg of oral estradiol produced an average blood level around 66 pg/mL, while 2 mg produced about 108 pg/mL — not double. The researchers concluded serum estradiol is not directly proportional to dose (serum-level study, PMC7878477).
Patch vs pill: why the route changes your risk, not just the number
Two forms can be "dose-equivalent" and still carry different risks. Because the patch skips first-pass liver metabolism, The Menopause Society notes that transdermal routes (patch, gel, spray) and lower doses may lower the risk of blood clots and stroke compared with estrogen pills.
The Menopause Society's 2022 position statement puts it directly: transdermal routes and lower doses may decrease the risk of venous thromboembolism (VTE) and stroke (Menopause, 2022). This is a real, sourced difference — not marketing.
Triglycerides example
In one randomized trial, oral conjugated estrogen raised triglycerides by about 21%, while a transdermal patch lowered them by about 9% over a year — same purpose, different effect, because of the route (PMC3234057).
SHBG and libido
The patch also has a smaller effect on SHBG (a protein that binds testosterone), which is one reason The Menopause Society notes transdermal estrogen may be preferable when libido and free testosterone are a concern (Menopause, 2022).
None of this means "switch to a patch." It means route is part of the conversation, and a good prescriber weighs your history before deciding.
How do you convert an estradiol patch to gel or spray?
You don't convert it by matching the numbers — gels and sprays are labeled by different measures than patches, and the amount in a "dose" of gel or spray isn't the amount that reaches your body per day. Gels and sprays are also transdermal, so they share the patch's route advantages. The catch: "gel" isn't one product, and you can't eyeball it from a package.
| Gel or spray | What one dose contains | Rough comparison |
|---|---|---|
| Divigel (packets) | 0.25, 0.5, 0.75, 1.0, or 1.25 mg per packet; usual start 0.25 mg | 0.5 mg ≈ low band (25–37.5 mcg patch); 1.0 mg ≈ standard band (50 mcg patch); U.S. max about 1.25 mg/day |
| EstroGel | 1 pump = 0.75 mg | One pump per day is the only FDA-approved dose for hot flashes — it isn't titrated by pump count in U.S. labeling |
| Elestrin | 1 pump = 0.52 mg | Usual starting dose; adjusted by response |
| Evamist (spray) | 1 spray = 1.53 mg | Start 1 spray daily, up to 3 sprays; not a number-for-number patch match |
Sources: FDA/DailyMed labels for Divigel, EstroGel, Elestrin, and Evamist; low/standard band comparisons from the Canadian Menopause Society. Note the mismatch: a spray delivering "1.53 mg" per spray looks enormous next to a "0.05 mg" patch — but those numbers measure completely different things (amount applied vs amount absorbed per day). Match the dose band with your prescriber, not the numbers.
How do you switch from one estradiol patch brand to another?
Start with two questions: is the daily delivery rate the same (50 mcg/day to 50 mcg/day?), and did the schedule change (once weekly vs twice weekly)? If the delivery rate matches, you're usually in the same dose band. But once-weekly and twice-weekly patches differ in adhesive, size, and total contents.
| Schedule | Example products | Change how often | Strengths (mg/day) | 0.06 mg/day? |
|---|---|---|---|---|
| Twice-weekly | Vivelle-Dot, Minivelle, Alora, Dotti, Lyllana, generics | Every 3–4 days | 0.025, 0.0375, 0.05, 0.075, 0.1 | No |
| Once-weekly | Climara, weekly generics | Every 7 days | 0.025, 0.0375, 0.05, 0.06, 0.075, 0.1 | Yes (Climara) |
| Once-weekly (bone only) | Menostar | Every 7 days | 0.014 | — |
Schedules and strengths: FDA/DailyMed labels. Verify the exact product, schedule, and strength your pharmacy dispenses.
Combination patches — not a simple swap
CombiPatch (estradiol + norethindrone, twice weekly) and Climara Pro (estradiol + levonorgestrel, once weekly) carry a progestogen too. If you have a uterus, that progestogen helps protect the uterine lining, so a "brand switch" that drops it isn't a simple swap (Mayo Clinic; DailyMed).
About the current shortage (ASHP, April 2026)
Several patch products — including certain Dotti and Lyllana strengths — were on back order with no estimated release date, while Climara, Viatris, and Sandoz patches stayed available; it varies by manufacturer, strength, and pack size. Demand has jumped (U.S. HRT prescriptions for women 50–65 are up roughly 86% since 2021, per Epic Research), and rose further after the FDA removed HRT's decades-old boxed warning in late 2025. If your patch is out of stock: don't stretch old patches, double up, cut them, or switch routes on your own. Ask your pharmacist whether the substitute is the same delivery rate and schedule, and whether your dose band is meant to stay the same.
Can you cut an estradiol patch to change the dose?
No — not as a general rule. Mayo Clinic says "Do not cut it," and Cleveland Clinic says "Do not cut or trim the patch." Cutting can change how the patch releases medication and how well it sticks, and manufacturers don't guarantee a cut patch will work as intended.
If your dose feels too high, too low, too expensive, or the patch is irritating your skin, the fix isn't scissors — it's a different labeled strength, brand, schedule, or route. That's a five-minute conversation with your prescriber or pharmacist, and it keeps your dosing predictable.
What this chart can't convert (and shouldn't)
Some things look like they belong on a conversion chart but don't — and treating them like they do is where real mistakes happen.
| Product or situation | Can this chart convert it? | Why not |
|---|---|---|
| Low-dose vaginal estrogen | No | It's a low, local dose for vaginal and urinary symptoms — very little reaches the rest of your body, so it's not a stand-in for a systemic patch (NHS). See our vaginal estrogen guide for that decision. |
| Compounded estrogen cream | No | Compounded (custom-mixed) products are not FDA-approved. The FDA does not verify their safety, effectiveness, or quality before they're sold, and doses aren't standardized the way approved products are (FDA). More in our FDA-approved vs compounded HRT guide. |
| Cutting a patch | No | Patient references advise against cutting estradiol patches (Mayo Clinic; Cleveland Clinic). |
| A blood estradiol level alone | No | Levels often don't match symptoms, and routine monitoring generally isn't recommended (Canadian Menopause Society). |
| A dose for a specific person | No | Your dose depends on symptoms, age, uterus status, risk history, product, and response — that's a prescriber's call (The Menopause Society). |
Compounded hormones — an important distinction
FDA-approved and compounded are not the same thing, and we keep them strictly separate. Do not use the patch dose bands on this page to guess a compounded cream's dose, and don't assume a compounded product is safer, more natural, or equivalent to an FDA-approved one. If a provider has proposed a compounded product, that's a good moment to ask why an FDA-approved option wasn't a fit.
Not sure if you need systemic HRT or something local?
The HRT Index's Find My HRT Path tool helps sort whether your symptoms point to a whole-body approach (patch, pill, gel) or a local one — before you pick a provider or pay for anything.
Check my situation →What to ask your prescriber before you switch doses or routes
Before switching from a patch to a pill, gel, spray, or a different patch, get five things confirmed: the intended dose band, the exact product, the schedule, your progestogen plan if you have a uterus, and what symptoms should prompt a call. The point isn't to memorize a chart — it's to make your next appointment shorter, clearer, and safer.
| Ask about | The question |
|---|---|
| Dose band | "Is my new dose meant to be low, standard, moderate-high, or high compared with my current patch?" |
| Reason | "Are we switching for symptoms, side effects, clot-risk reasons, cost, shortage, or preference?" |
| Product | "Is this FDA-approved estradiol, and exactly which product or generic will the pharmacy give me?" |
| Schedule | "Is this once weekly, twice weekly, a daily gel, a daily spray, or a daily pill?" |
| Uterus | "Do I need progesterone, or a change to it, because I have a uterus?" |
| Safety | "What bleeding, breast, clot, migraine, or blood-pressure symptoms should make me call you?" |
| Follow-up | "When should we check whether my symptoms are actually controlled?" |
| Backup | "What do I do if the pharmacy doesn't have this exact patch or dose?" |
Walk into your appointment ready
Find My HRT Path turns your situation into a focused list of what to discuss and what to verify, so you're not figuring it out in the exam room.
Prepare for my appointment →How we built this estradiol patch dose conversion chart
We separated three different kinds of information, because blending them is how charts go wrong. Verified product facts (patch strengths, schedules, gel and spray amounts, total contents) came from FDA/DailyMed labels. Dose-band comparisons came from menopause equivalency guidance, treated as approximate ranges — not prescribing instructions. And the "who this fits" judgments are clearly labeled as editorial, not medical advice.
What we actually verified —
- FDA/DailyMed estradiol patch strengths, schedules, and total contents (once-weekly and twice-weekly systems, including Climara's 0.06 mg/day and Menostar's 14 mcg/day).
- FDA/DailyMed amounts for oral estradiol, EstroGel (single approved 1-pump dose), Elestrin, Divigel, and Evamist.
- Canadian Menopause Society dose-band equivalencies for oral estradiol, Premarin, and patches.
- The Menopause Society (2022) guidance on route, blood-clot risk, and individualized care.
- KEEPS and a serum-level study for the standard-dose anchor and the "levels aren't proportional to dose" point.
- FDA's position on compounded drugs; Mayo Clinic and Cleveland Clinic patient instructions on not cutting patches; ASHP's current shortage listing.
What we did not verify: any individual's blood levels, personal dosing needs, pharmacy-specific substitutions, insurance coverage, or whether online care is right for a specific reader. Those require a clinician.
See our methodology and medical review policy. We're editorial researchers, not your doctor. This page exists to make you a sharper, calmer patient before your consult — not to replace it.
Frequently asked questions
- What is a 0.05 mg estradiol patch equivalent to?
- A 0.05 mg/day estradiol patch is the same as a 50 mcg/day patch. In menopause dose-band charts it's the standard dose and is commonly compared to about 1 mg of oral estradiol or 0.625 mg of Premarin — as an approximation, not an exact personal conversion (Canadian Menopause Society; KEEPS).
- Is a 0.0375 estradiol patch a low dose?
- Yes. 0.0375 mg/day equals 37.5 mcg/day and sits in the low-dose band. But "low" doesn't mean inactive — some twice-weekly patch labels use 0.0375 mg/day as a starting dose for moderate to severe hot flashes (FDA prescribing label).
- Is a 0.1 mg estradiol patch a high dose?
- Yes. A 0.1 mg/day patch is 100 mcg/day and is generally the high systemic band. It's not a "better" dose by default — high-dose use should be individualized and monitored by a clinician (Canadian Menopause Society).
- What estradiol patch dose equals 2 mg of oral estradiol?
- The Canadian Menopause Society lines 2 mg of oral estradiol up with a 75 mcg/day patch (moderate-high); some older references put it closer to a 100 mcg patch. Either way it's a mid-to-high systemic dose — confirm the exact target with your clinician.
- What is the highest estradiol patch dose?
- Among common FDA-approved strengths, patches go up to 0.1 mg/day (100 mcg). Once-weekly and twice-weekly products can differ in schedule, size, and total contents even when the daily delivery rate matches (FDA/DailyMed label).
- Are estradiol patches stronger than pills?
- Not stronger — different. Equivalent doses aim for a similar effect, but because the patch skips first-pass liver metabolism, transdermal routes may carry a lower risk of blood clots and stroke than pills (The Menopause Society, 2022). The right choice depends on your history.
- Can I switch from an estradiol patch to gel during a shortage?
- Possibly — but not by copying a chart. Ask your prescriber which dose band they intend, which gel product you'll get, how to apply it, whether your progesterone plan changes, and when to reassess. As of April 2026, some patches were on back order while others stayed available (ASHP), so a shortage switch should be pharmacy-confirmed.
- Can I cut my estradiol patch in half?
- No, not as a general rule. Mayo Clinic and Cleveland Clinic patient instructions advise against cutting estradiol patches, and manufacturers don't guarantee a cut patch will work correctly. If the dose is wrong, ask about a different labeled strength instead.
- Does a higher estradiol patch dose mean I need more progesterone?
- If you have a uterus and use systemic estrogen, your clinician manages uterine-lining protection, and higher estrogen doses can call for more progestogen. That's a prescriber decision, never a self-adjustment (Canadian Menopause Society).
- Are estradiol blood levels enough to choose a dose?
- Usually not. Clinical response often doesn't match blood levels, and routine estradiol monitoring generally isn't recommended except in select non-response situations (Canadian Menopause Society). For most women, dose follows symptom relief.
- Is vaginal estrogen equivalent to an estradiol patch?
- No. Low-dose vaginal estrogen is local therapy for vaginal and urinary symptoms — very little reaches the rest of your body — while a patch is whole-body (systemic) therapy (NHS). They're not interchangeable.
- Are compounded estrogen creams included in this chart?
- No. This chart is for FDA-approved products with labeled strengths. The FDA does not approve compounded drugs or verify their safety, effectiveness, or quality before they're sold, and their doses aren't standardized (FDA).
Still deciding your next step?
If your patch strength finally makes sense but you're not sure whether online care is your right starting point — or which provider model fits your symptoms, state, and insurance — that's exactly what our free tool is for.
Take our free matching quiz →The HRT Index is reader-supported. We may earn a commission if you choose certain providers after using our tools, at no cost to you. That never changes our editorial research or which options we recommend. FDA-approved and compounded options are always labeled distinctly.
Sources
- U.S. FDA / DailyMed — Estradiol transdermal system (twice-weekly) prescribing label. dailymed.nlm.nih.gov
- DailyMed — DOTTI (estradiol transdermal system) label — twice-weekly; total contents. dailymed.nlm.nih.gov
- DailyMed / Bayer — CLIMARA label — once-weekly; 0.06 mg/day; total contents. dailymed.nlm.nih.gov
- DailyMed — MENOSTAR label — 14 mcg/day, osteoporosis prevention. dailymed.nlm.nih.gov
- DailyMed — ESTROGEL 0.06% label — single approved 1-pump (0.75 mg) dose. dailymed.nlm.nih.gov
- DailyMed / Drugs.com — DIVIGEL / estradiol gel label — packet strengths 0.25–1.25 mg. dailymed.nlm.nih.gov
- U.S. FDA / DailyMed — EVAMIST (estradiol spray) label — 1.53 mg per spray. dailymed.nlm.nih.gov
- Drugs.com — Estradiol Dosage Guide (gel and spray amounts; Divigel maximum). drugs.com
- Mayo Clinic — Estradiol (transdermal route). mayoclinic.org
- Cleveland Clinic — Estradiol Skin Patches. my.clevelandclinic.org
- Canadian Menopause Society — Systemic MHT Equivalency Table. canadianmenopausesociety.org
- The Menopause Society (NAMS) — The 2022 Hormone Therapy Position Statement. Menopause 2022;29(7):767–794.
- Santoro N, et al. — KEEPS: menopausal symptoms with low-dose oral conjugated estrogens or transdermal estradiol vs placebo. Menopause 2017;24(3):238–246. PMC5323337
- Serum estradiol by dose and formulation. pmc.ncbi.nlm.nih.gov/articles/PMC7878477
- Randomized transdermal-vs-oral HRT trial — route and cardiovascular risk biomarkers. pmc.ncbi.nlm.nih.gov/articles/PMC3234057
- Pharmacokinetic crossover study of transdermal vs oral estrogens. pubmed.ncbi.nlm.nih.gov/2992279
- MedlinePlus — Estradiol Transdermal Patch. medlineplus.gov
- NHS — Benefits and risks of hormone replacement therapy (HRT). nhs.uk
- U.S. FDA — Compounding and the FDA: Questions and Answers. fda.gov
- ASHP — Drug Shortages: Estradiol Transdermal System (updated April 2026). ashp.org
- Epic Research — menopausal hormone therapy prescribing trends. epicresearch.org
- FDA removal of the hormone therapy boxed warning (late 2025), as reported by CNBC and NBC News (2026).